couter

ARGXargenx SE

Health CareBiotechnology
Oct 22, 2026 — Q3 2026 Earnings Release
Chart by TradingView

The schedule

  • Thu22Oct

    Q3 2026 Earnings Release assessing Vyvgart commercial expansion.

  • Fri20Nov

    Key pipeline updates on label expansion for subcutaneous delivery and CIDP indications.

  • Tue9Feb

    Q4 2026 Earnings Release and initial FY2027 revenue guidance.

  • Thu15Apr

    Market digestion of competing FcRn data and evolving PBM formulary positioning.

  • Thu29Jul

    Q2 2027 Earnings assessing mid-year commercial execution and potential target upgrades.